Presentation TCT 2016 Identifying and Treating Benign Discontinuities From More Meaningful Intraluminal Scaffold Dismantling and Fractures (With Case Examples) Presenter: Ashok Seth, Pieter C. Smits, Yoshinobu Onuma November 01, 2016
Presentation TCT 2016 What Is Known (and What Is Not) About Discontinuing Aspirin or Clopidogrel in Patients on Chronic Oral Anticoagulants Plus DAPT Presenter: David P. Faxon, C. Michael Gibson, Freek W.A. Verheugt November 01, 2016
Presentation TCT 2016 Improving Clinical Science: Priorities and Methods of Clinical Trials in Cardiovascular Regenerative Medicine Presenter: Emerson C. Perin, Bernard J. Gersh October 31, 2016
Presentation TCT 2016 Cells at the Moment of Truth: Findings From Meta-analysis and Systematic Reviews Presenter: Emerson C. Perin, Mariann Gyöngyösi October 31, 2016
Presentation TCT 2016 Beyond Cells: Cardiac Gene Therapy In Perspective Presenter: Emerson C. Perin, Marc S. Penn October 31, 2016
Presentation TCT 2016 New Sights from CHART -1 at 1 Year: Relationship of outcomes to baseline biomarkers and treatment intensity Presenter: Emerson C. Perin, Jozef Bartunek October 31, 2016
Presentation TCT 2016 Cells Alone Work: Lessons From Recent Clinical Trials Presenter: Emerson C. Perin October 31, 2016
Presentation TCT 2016 When Everything Has Disappeared: Role of Cell-Based Engineered Tissue and Organ Transplantation. Presenter: Timothy D. Henry, Amit N. Patel, Doris A. Taylor October 31, 2016
Presentation TCT 2016 When Cells are Not Enough: Role of Cellular and Non-Cellular Injectable Biomaterials Presenter: Timothy D. Henry, Amit N. Patel October 31, 2016
Presentation TCT 2016 Site-reported vs Core Lab Syntax Scores: Discordance and Impact on Outcomes After PCI vs CABG in EXCEL Presenter: A. Pieter Kappetein, Marie-Claude Morice, Philippe Généreux October 31, 2016
Presentation TCT 2016 Improving Translational Science In Cardiac Regenerative Medicine. Utility of Animal Models Presenter: Timothy D. Henry, Amit N. Patel, Steven A.J. Chamuleau October 31, 2016
Presentation TCT 2016 Obstacles for Clinical Research: Perspectives From Industry Presenter: Emerson C. Perin, Ricardo Sanz-Ruiz, Warren Sherman October 31, 2016
Presentation TCT 2016 Obstacles for Clinical Research: The BAMI Experience Presenter: Emerson C. Perin, Ricardo Sanz-Ruiz October 31, 2016
Presentation TCT 2016 Regenerative Products In Perspective: Do They Really Work? Are They Enough? Presenter: Emerson C. Perin, Ricardo Sanz-Ruiz, Jens Kastrup October 31, 2016
Presentation TCT 2016 Differences Between US and Japan in OAT Discontinuation and Risk of Major Bleeds, and Who are the Best LAA Closure Device Candidates in Both Countries Presenter: Mitchell W. Krucoff, Shigeru Saito, Christopher B. Granger October 30, 2016
Presentation TCT 2016 TCT 513: Discordance In Stenosis Classification by Pressure-Only Indices of Stenosis Severity is Related to Differences in Coronary Flow Reserve the RESOLVING DISCORD Study Presenter: Michalis Hamilos, Pim A.L. Tonino October 30, 2016
Presentation Premature Clopidogrel Discontinuation After DES Placement in a Large Urban Safety-Net Hospital Presenter: H. Khalili December 09, 2015
Presentation TCT 2015 First-in-Man Experience With Human Embryonic Stem Cell-Derived Progenitors for Heart Failure Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Philippe Menasché October 15, 2015
Presentation TCT 2015 Debate: Are We Really Ready for Phase III Trials? For Limb Ischemia There Are Knowns and Unknowns! Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Amit Patel October 15, 2015
Presentation TCT 2015 Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns! Presenter: Francisco Fdez-Aviles, Timothy D. Henry October 15, 2015